GEICO Files $1.2 Million RICO Suit Over Alleged DME Fraud

In a significant legal move, GEICO has filed a federal lawsuit claiming that two durable medical equipment (DME) companies engaged in a fraudulent scheme to bill the insurer over $1.2 million for unnecessary medical supplies. The complaint, lodged on September 1, 2026, in the US District Court for the Eastern District of New York, highlights a troubling pattern of alleged abuse within the No-Fault insurance system, primarily impacting auto insurers and policyholders in New York. By asserting claims under the Racketeer Influenced and Corrupt Organizations Act (RICO), GEICO aims to hold accountable those who manipulate the system for illicit financial gain.

The allegations detail a complex web of deceit involving collusion between the DME suppliers and unnamed operators of several clinics across the New York metropolitan area. This case not only reflects the challenges insurers face in combating fraud but also underscores the critical need for regulatory oversight in the healthcare and insurance sectors.

Understanding the Allegations

At the heart of GEICO's lawsuit are claims that the two DME companies operated as part of a single fraudulent entity, designed to exploit the No-Fault insurance system. According to the complaint, the companies billed GEICO for medical equipment that was either never provided or unnecessary for the patients involved.

Key Players in the Scheme

The lawsuit names three individuals allegedly involved in operating the two DME companies. None of these individuals hold licenses as healthcare providers, raising questions about their ability to make legitimate medical judgments regarding the equipment billed to insurers. GEICO claims that between 2019 and the present, these companies submitted bills totaling more than $1.2 million, including over $451,000 already paid and additional pending bills of $588,000 that GEICO argues should not be paid.

How the Fraud Allegedly Worked

Central to the scheme are what GEICO describes as "predetermined fraudulent protocols." The complaint alleges that patients were routinely prescribed the same package of medical equipment regardless of their individual needs. This package typically included lumbar braces, cervical collars, and various other devices that patients were unlikely to require after minor accidents.

Collusion with Clinics

GEICO asserts that the DME companies acquired their prescriptions through collusive arrangements with operators at six clinics located throughout the New York area. These clinics allegedly funneled prescriptions directly to the DME companies without involving the patients. This bypassing of the patients potentially led to inflated orders that a legitimate supplier would likely have scrutinized more closely.

• Kickbacks were allegedly paid to ensure a steady flow of prescriptions.
• Billing codes were misused to inflate charges, significantly exceeding allowable limits.
• Prescriptions were often signed with forged or photocopied signatures, raising serious ethical and legal concerns.

Financial Implications of the Alleged Fraud

The financial repercussions for GEICO are substantial. The insurer claims that the companies fraudulently billed for equipment at rates far exceeding those allowed under standard insurance guidelines. For instance, lumbar braces billed at $800 were not custom-fitted as claimed but rather were off-the-shelf items that a patient could adjust themselves. GEICO alleges that the companies billed them using code L0631, which is reserved for custom-fitted braces, resulting in significant overcharges.

Inflated Rates and Improper Billing

GEICO's complaint details various instances of improper billing practices. For example, one DME company allegedly billed for cold therapy units and continuous passive motion machines using a catch-all "miscellaneous" code at $75 per day, while the actual allowable rates were significantly lower—$5.48 per week for cold therapy units, and $132.16 per week for passive motion machines. Such discrepancies highlight the systemic issues within the billing practices of some DME suppliers.

The Legal Framework and GEICO's Response

GEICO's legal action invokes RICO, a federal law originally designed to combat organized crime, which allows plaintiffs to seek triple damages for losses suffered due to racketeering. By targeting both the DME companies and the individual defendants, GEICO seeks to not only recover its losses but also to deter similar fraudulent activities in the future.

Claims Under RICO and Other Legal Avenues

The lawsuit comprises 12 distinct claims, including six under RICO, alongside fraud claims and assertions of unjust enrichment. GEICO is not only asking for the court to declare that it owes nothing on the pending $588,000 in bills but also seeking punitive damages, legal fees, and the opportunity for a jury trial. The outcome of this case could set a precedent for how insurers address fraudulent billing practices in the future.

Key Takeaways

• GEICO alleges over $1.2 million in fraudulent No-Fault claims by two DME companies.
• The case highlights significant issues of oversight in the medical supply industry.
• GEICO seeks triple damages under RICO, which could have broader implications for similar cases.
• The outcome may influence future regulatory practices in the insurance and healthcare sectors.
• Policyholders should be aware of potential fraudulent claims impacting their insurance premiums.

Frequently Asked Questions

What is the significance of GEICO's RICO claims?

The Racketeer Influenced and Corrupt Organizations Act (RICO) allows plaintiffs to pursue not only damages for their losses but also to seek triple damages if they can prove racketeering activity. This legal strategy aims to deter organized fraud schemes by imposing severe financial consequences on those involved. In GEICO's case, successful RICO claims could also lead to stricter scrutiny of DME suppliers and better protection for policyholders against fraudulent practices.

How can consumers protect themselves from insurance fraud?

Consumers can take several proactive steps to protect themselves from insurance fraud. It's essential to review medical bills carefully, question any charges that seem inflated or unnecessary, and ensure that all prescriptions and treatments are well-documented and justified. Keeping track of treatment histories and communicating directly with healthcare providers can also help prevent misunderstandings and potential fraud.

What are the implications for the No-Fault insurance system?

This case brings to light significant vulnerabilities within the No-Fault insurance system, which is designed to ensure that accident victims receive prompt medical care without needing to establish fault. However, the alleged fraudulent activities may undermine the integrity of the system, leading to increased costs for insurers, which could ultimately be passed on to consumers in the form of higher premiums. Ongoing scrutiny and regulatory reforms may be necessary to protect all stakeholders involved.